Standard BioTools™ will be in San Diego, CA, from April 5–10 for the American Association for Cancer Research’s Annual Meeting. The AACR Annual Meeting is the focal point of the cancer research community at which scientists, clinicians, healthcare professionals, survivors, patients and advocates gather to share the latest advances in cancer science and medicine and highlight the work of the best minds in cancer research from institutions all over the world.

We are thrilled to provide tools and services to help support advances in immuno-oncology research. Leading researchers around the world apply our technologies to advance biomarker discovery and development, enable improved profiling of chimeric antigen receptor cell products and identify gene expression signatures from immune and cancer cells, all in an effort to better understand how the immune system responds to cancer and potential immunotherapy treatments.

Visit Booth 1631 to learn more about how our tools and technologies are designed to meet the rigorous demands of translational and clinical research programs and explore our latest cutting-edge product innovations.

Visit Booth 3718 to meet the Standard BioTools SomaLogic division. SomaLogic is a leader in high-plex proteomics, providing sensitivity, specificity, reproducibility and scale, using aptamer technology, to advance biomarker discovery in a variety of therapeutic research areas and drug development with the SomaScan® Assay.